Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance

BACKGROUND: The Gambia introduced seven-valent pneumococcal conjugate vaccine (PCV7) in August 2009, followed by PCV13 in May, 2011, using a schedule of three primary doses without a booster dose or catch-up immunisation. We aimed to assess the long-term impact of PCV on disease incidence. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Mackenzie, Grant A, Hill, Philip C, Jeffries, David J, Ndiaye, Malick, Sahito, Shah M, Hossain, Ilias, Uchendu, Uchendu, Ameh, David, Adeyemi, Oyedeji, Pathirana, Jayani, Olatunji, Yekini, Abatan, Baderinwa, Muhammad, Bilquees S, Ahameefula, Ebirim, Fombah, Augustin E, Adeshola, Banjo, Lobga, Babila G, Saha, Debasish, Mackenzie, Roslyn, Odutola, Aderonke, Plumb, Ian D, Akano, Aliu, Ebruke, Bernard E, Ideh, Readon C, Kuti, Bankole, Githua, Peter, Olutunde, Emmanuel, Ofordile, Ogochukwu, Green, Edward, Usuf, Effua, Badji, Henry, Ikumapayi, Usman NA, Manjang, Ahmed, Salaudeen, Rasheed, Nsekpong, E David, Jarju, Sheikh, Antonio, Martin, Sambou, Sana, Ceesay, Lamin, Lowe-Jallow, Yamundow, Fofana, Sidat, Jasseh, Momodou, Mulholland, Kim, Knoll, Maria, Levine, Orin S, Howie, Stephen R, Adegbola, Richard A, Greenwood, Brian M, Corrah, Tumani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science ;, The Lancet Pub. Group 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384632/
https://www.ncbi.nlm.nih.gov/pubmed/34280357
http://dx.doi.org/10.1016/S1473-3099(20)30880-X

Ejemplares similares

Ejemplares similares